Search

Your search keyword '"Siegel, Jeffrey"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Siegel, Jeffrey" Remove constraint Author: "Siegel, Jeffrey" Database OAIster Remove constraint Database: OAIster
41 results on '"Siegel, Jeffrey"'

Search Results

1. FDA/Arthritis Foundation osteoarthritis drug development workshop recap: Assessment of long-term benefit.

2. Electrostatic precipitators as an indoor air cleaner— a literature review

3. Tocilizumab in systemic sclerosis:a randomised, double-blind, placebo-controlled, phase 3 trial

4. Tocilizumab in systemic sclerosis:a randomised, double-blind, placebo-controlled, phase 3 trial

5. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

6. A communal catalogue reveals Earth's multiscale microbial diversity

7. A communal catalogue reveals Earth’s multiscale microbial diversity

8. A communal catalogue reveals Earth's multiscale microbial diversity

9. A communal catalogue reveals Earth’s multiscale microbial diversity

10. A communal catalogue reveals Earth’s multiscale microbial diversity

19. Geography and Location Are the Primary Drivers of Office Microbiome Composition.

20. Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate) : a phase 2, randomised, controlled trial

21. Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate) : a phase 2, randomised, controlled trial

22. Geography and Location Are the Primary Drivers of Office Microbiome Composition.

23. Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate) : a phase 2, randomised, controlled trial

24. The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis.

25. The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis.

26. Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

34. Spatial and temporal variations in indoor environmental conditions, human occupancy, and operational characteristics in a new hospital building.

35. Spatial and temporal variations in indoor environmental conditions, human occupancy, and operational characteristics in a new hospital building.

36. The Hospital Microbiome Project: Meeting Report for the 1st Hospital Microbiome Project Workshop on sampling design and building science measurements, Chicago, USA, June 7th-8th 2012.

37. The Hospital Microbiome Project: Meeting Report for the 1st Hospital Microbiome Project Workshop on sampling design and building science measurements, Chicago, USA, June 7th-8th 2012.

38. Analysis of life cycle cost methods for heating, ventilation, and air conditioning systems in hospitals

39. Analysis of life cycle cost methods for heating, ventilation, and air conditioning systems in hospitals

41. Signal Transduction in T Cell Activation and Tolerance

Catalog

Books, media, physical & digital resources